Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook 
SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments 
Trump Buys SpaceX Shares After Record IPO 
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 
China EV Stocks Slide as Door Handle Recall Hits 4.3 Million Vehicles 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
Ampol Profit Surges as Refining Margins Hit Record Highs 
Tesla Raises Cybertruck Prices by $5,000 in US 
J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Nvidia AI Server Prices Set to Rise as Memory Costs Surge 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Exxon, LyondellBasell Eye Shell’s $8 Billion U.S. Chemicals Assets 
California Seeks Paramount Divestitures in Warner Bros. Merger 
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover 
Bathla Group Hires Administrators as Australia Housing Slump Deepens 
Add as a preferred source on Google
NEW YORK, April 30, 2018 -- Maxim Group LLC, a leading full service investment banking, securities and wealth management firm today announced the expansion of its Equity Research platform with the appointment of Caroline Palomeque as a Senior Vice President and Senior Biotechnology Analyst.
Prior to joining Maxim Group, Ms. Palomeque was a Senior Research Analyst covering the Biotechnology sector at Noble Life Science Partners and WallachBeth Capital. She has equity research experience at Oppenheimer, JMP Securities, Goldman Sachs, and Natexis Bleichroeder. Ms. Palomeque has conducted research at Mount Sinai School of Medicine in molecular epidemiology and neurotoxins. She also coauthored several scientific papers which were peer-reviewed academic journals. “I am pleased to add someone with Caroline’s experience background to our Healthcare Platform. Healthcare is a core vertical at Maxim Group and Biotechnology is an important component,” said Anthony V. Vendetti, Executive Managing Director and Head of Equity Research at Maxim Group.
Ms. Palomeque holds an M.B.A. in Finance from Fordham University Graduate School of Business and a B.S. in Neuroscience from the University of Massachusetts Amherst.
About Maxim Group LLC
Maxim Group LLC is a full-service investment banking, securities and wealth management firm headquartered in New York. The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed-income and derivatives sales & trading, equity research and prime brokerage services to a diverse range of corporate clients, institutional investors and high net worth individuals. Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission (SEC) and the Municipal Securities Rulemaking Board (MSRB), and is a member of the following: Financial Industry Regulatory Authority (FINRA); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and NYSE Arca, Inc. To learn more about Maxim Group, visit www.maximgrp.com.
For further information please contact:
John J. Garrity
Chief Marketing Officer
212.895.3624
[email protected]
